#BreastCancer #SEOM #Oncology [#SpainHealth]() #CancerResearch # Spain expects 38,318 breast cancer cases in 2026 19 October 2026 at 19:53 > The Spanish Society of Medical Oncology reports rising incidence among younger women as the national screening age is lowered to 45. The **Spanish Society of Medical Oncology** (SEOM) estimates that 38,318 women in **Spain** will be diagnosed with breast cancer by 2026. Over 6,600 deaths are expected, including nearly 100 men, though the five-year survival rate remains high at up to 87 per cent. Approximately 3,000 cases annually involve women under 40, a demographic where incidence rises globally by 0.5 per cent each year. While rare under 30, cases peak between 35 and 40. The **Ministry of Health** has now lowered the screening age to 45 years. Diagnosis during or after pregnancy carries a worse prognosis, particularly as Spain has one of **Europe**'s oldest average ages for first pregnancies. Research by oncologist **María Vidal** notes that cancers in younger women often exhibit more aggressive biology. ## Related news #Wegovy #ObesityTreatment #NovoNordisk [#SpainHealth]() #GLP1 3 November 2026 at 14:50 ## [Novo launches oral Wegovy for obesity in Spain]() > Novo Nordisk introduces the first daily oral GLP-1 pill for weight management in Spain following European Commission approval. [#Spain]() #BreastCancer [#PublicHealth]() #Mammography [#Healthcare]() 23 October 2026 at 16:40 ## [Spain expands breast cancer screening to age 74]() > The Ministry of Health and regions agree to offer mammographies to women aged 45 to 74 while updating orthoprosthetic benefit coverage. #Lenzetto [#Aemps]() #Menopause #HormoneReplacementTherapy [#SpainHealth]() 2 October 2026 at 20:30 ## [Spain warns of menopause drug shortage extension]() > The Aemps alerts that Lenzetto and Evopad supply issues could persist past November 2026 due to manufacturing problems and high demand.